Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06396871

Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases

Status
Recruiting
Phase
Study type
Observational
Enrollment
180 (estimated)
Sponsor
Technische Universität Dresden · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and circulating factors (proteins, metabolites, lipids, extracellular vesicles) in different stages of several metabolic diseases (diabetes, obesity, non-alcoholic fatty liver disease) that share common pathophysiological mechanisms and in comparison with adult healthy controls. The main question\[s\] it aims to answer are: * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in platelets in patients with metabolic diseases vs subjects without metabolic diseases * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in leucocytes or circulating molecules in patients with metabolic diseases vs subjects without metabolic diseases

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOral glucose tolerance test75g of a standardized glucose solution followed by blood draw at 0, 30, 60, 90, 120 min
DIAGNOSTIC_TESTLiver UltrasoundA crude assessment of liver status in order to identify the presence of steatosis or not will take place with ultrasound.
DIAGNOSTIC_TESTFibroscan of the LiverFibroScan non-invasively measures the stiffness of the liver by capturing and calculating the speed of a shear wave as it travels through the liver (vibration controlled transient elastography).
DIAGNOSTIC_TESTMagentic Resonance Imaging (MRI) of the liverThe exact calculation of liver fat with proton density fat fraction will take place with MRI.

Timeline

Start date
2023-10-16
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2024-05-02
Last updated
2024-05-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06396871. Inclusion in this directory is not an endorsement.